Ophthotech Corporation (ISEE)
(Delayed Data from NSDQ)
$1.43 USD
+0.08 (5.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.43 (%) 5:22 PM ET
NA Value NA Growth NA Momentum NA VGM
View All Zacks #1 Ranked Stocks
Brokerage Reports
[ISEE]
Reports for Purchase
Showing records 41 - 60 ( 107 total )
Industry: Medical - Biomedical and Genetics
Price: 12.50
Industry: Medical - Biomedical and Genetics
Will ISEE a Celebration When We GATHER2-gether?
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Price: 12.50
Industry: Medical - Biomedical and Genetics
ISEE Sets Its Sights on Extended Release Zimura
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Price: 5.00
Industry: Medical - Biomedical and Genetics
Price: 12.50
Industry: Medical - Biomedical and Genetics
Price: 50.00
Industry: Medical - Biomedical and Genetics
Near-Term GATHER2 Topline Expected 3Q22-Setting Stage for Zimura in GA dAMD
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Price: 12.50
Industry: Medical - Biomedical and Genetics
Price: 12.50
Industry: Medical - Biomedical and Genetics
Price: 12.50
Industry: Medical - Biomedical and Genetics
Views From the Summit - Preserving Vision From the Investing in Cures Summit 2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Price: 5.00
Industry: Medical - Biomedical and Genetics
The Wedbush Monthly Check-Up: April 2022
Provider: Wedbush Securities Inc.
Analyst: Research Department
Price: 25.00
Industry: Medical - Biomedical and Genetics
Price: 12.50
Industry: Medical - Biomedical and Genetics
GATHER2 Trial Approaching Pivotal Top Line 2H22; Considerations on Zimura Impact
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Price: 12.50
Industry: Medical - Biomedical and Genetics
Zimura Making Steady Progress to GATHER2 Data
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Price: 5.00
Industry: Medical - Biomedical and Genetics
Post-hoc Analysis Consistent With GATHER1; Focusing on GATHER2 Top Line 2H22
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Price: 5.00
Industry: Medical - Biomedical and Genetics
Price: 12.50
Industry: Medical - Biomedical and Genetics
Price: 25.00
Industry: Medical - Biomedical and Genetics
Zimura Pivotal GATHER2 Data on 2022 Horizon; Reiterate Buy, PT to $26
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Price: 12.50
Industry: Medical - Biomedical and Genetics
Ice, Ice, ISEE With a Nine...Month Wait for GATHER2
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Price: 12.50
Industry: Medical - Biomedical and Genetics
HEALTHCARE- The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Price: 12.50
Industry: Medical - Biomedical and Genetics
Price: 25.00